Abstract
Opioid use in the management of chronic pain is widespread. However, it is a recognized risk factor for the development of osteoporosis. The hypothesis of this study was to evaluate the effect of various analgesic drugs; morphine, fentanyl and tramadol, on the bone of adult female rats. Forty rats were divided into 4 groups; Control, morphine (8 mg/kg), fentanyl (32 μg/kg) and tramadol (10 mg/kg) groups. After 90 days of treatment, the serum calcium, alkaline phosphatase, osteocalcin and estradiol were assayed and the bones were prepared for histomorphometric study. In comparison to the control group, morphine and fentanyl groups showed a significant biochemical and histological osteoporotic changes while treatment with tramadol leads to non-significant osteoporotic effect. In conclusion, tramadol had the least osteoporotic effect as compared to morphine or fentanyl on chronic administration suggesting the safety use of tramadol in the treatment of patients with chronic pain particularly in association with osteoporosis.
Keywords: Osteoporsis, estradiol, morphine, fentanyl, tramadol
Current Drug Safety
Title: Evaluation of Osteoporosis Risk Associated with Chronic Use of Morphine, Fentanyl and Tramadol in Adult Female Rats
Volume: 6 Issue: 3
Author(s): Vivian Boshra
Affiliation:
Keywords: Osteoporsis, estradiol, morphine, fentanyl, tramadol
Abstract: Opioid use in the management of chronic pain is widespread. However, it is a recognized risk factor for the development of osteoporosis. The hypothesis of this study was to evaluate the effect of various analgesic drugs; morphine, fentanyl and tramadol, on the bone of adult female rats. Forty rats were divided into 4 groups; Control, morphine (8 mg/kg), fentanyl (32 μg/kg) and tramadol (10 mg/kg) groups. After 90 days of treatment, the serum calcium, alkaline phosphatase, osteocalcin and estradiol were assayed and the bones were prepared for histomorphometric study. In comparison to the control group, morphine and fentanyl groups showed a significant biochemical and histological osteoporotic changes while treatment with tramadol leads to non-significant osteoporotic effect. In conclusion, tramadol had the least osteoporotic effect as compared to morphine or fentanyl on chronic administration suggesting the safety use of tramadol in the treatment of patients with chronic pain particularly in association with osteoporosis.
Export Options
About this article
Cite this article as:
Boshra Vivian, Evaluation of Osteoporosis Risk Associated with Chronic Use of Morphine, Fentanyl and Tramadol in Adult Female Rats, Current Drug Safety 2011; 6 (3) . https://dx.doi.org/10.2174/157488611797579267
DOI https://dx.doi.org/10.2174/157488611797579267 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Quantifying Gp96/Grp94 Complexes Preparations for Vaccines: a Key Step Often Inaccurate
Current Medicinal Chemistry Spectroscopic and Theoretical Approaches for the Determination of Heparin Saccharide Structure and the Study of Protein-Glycosaminoglycan Complexes in Solution
Current Medicinal Chemistry Overactive Bladder - Current Treatment Modalities
Current Women`s Health Reviews Synthesis and Applications of Glyconanoparticles
Current Organic Chemistry Human Hepatocytes in Primary Culture: The Choice to Investigate Drug Metabolism in Man
Current Drug Metabolism QSAR as a Tool for the Development of Potent Antiproliferative Agents by Inhibition of Choline Kinase
Current Computer-Aided Drug Design Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease
Current Drug Targets Effectiveness of Resveratrol Against Cardiovascular Disease
Mini-Reviews in Organic Chemistry Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 2. Fundamental Concepts in Genetic Epidemiology
Current Psychiatry Reviews Nanostructured Multiporphyrin Dendrimers: Synthesis, Characterization and Their Spectroscopic Properties
Current Organic Chemistry Electrochemical Determination of Nicotine Poly (Alizarin red S) Modified Graphene Screen-Printed Carbon Electrode
Current Nanoscience An Overview on Chemistry and Biological Importance of Pyrrolidinone
Current Organic Synthesis The Last Decade of Carbon Paste Electrodes in DNA Electrochemistry
Current Analytical Chemistry Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Biological Activities and Docking Studies on Novel Bis 1,4-DHPS Linked to Arene Core via Ether or Ester Linkage
Letters in Drug Design & Discovery PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation
Current Drug Delivery Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters